Please login to the form below

Not currently logged in
Email:
Password:

Aeterna Zentaris looks to Boehringer for science head

Richard Sachse joins Canadian firm as chief scientific officer
Aeterna Zenaris Richard Sachse

Aeterna Zentaris has appointed Boehringer Ingelheim's Dr Richard Sachse as senior VP and chief scientific officer.

Dr Sachse was most recently head of global translational medicine at Germany-based Boehringer following several roles at major pharma companies in Europe, including Bayer, Schwarz Pharma and UCB.

He will now make the move to Canada to take on his role at Aeterna Zentaris, which specialises in oncology and endocrinology.

The company's president and CEO David Dodd outline Dr Sachse's new role: “As CSO, he will be responsible for all areas of our global research and development activities, while also serving on the corporate operating committee.”

Dr Sachse said he was “delighted” by the opportunity his new position offered him.

He said: “I believe that the combination of Aeterna Zentaris' highly qualified and motivated personnel, together with its strong scientific platform, holds much promise for the future success of our projects."

8th January 2014

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Four Health

Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...

Latest intelligence

Webinar: Usability and UX: You’ve been asked to test...What next?
Thursday 27th June 2019 10am EDT / 3pm BST / 4pm CEST...
Event: EphMRA Annual Conference
We're sponsoring, exhibiting and presenting three papers at this year’s EphMRA Annual Conference in Warsaw, Poland....
Research Partnership and Janssen awarded runner-up in MR Excellence Awards
...

Infographics